IDiyas

For the Inventor, By the Inventor

Wayne, NJ, United States of America

Norman W Gilman

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:

goldMedal13 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1978-1995

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5428004 - Compounds useful as dual antagonists of platelet activating factor and (1995-06-27),
2. 5302590 - Compounds useful as dual antagonists of platelet activating factor and (1994-04-12),
3. 4973599 - Phenylthioheterocyclic derivatives (1990-11-27),
4. 4777169 - Benzodiazepine derivatives (1988-10-11),
5. 4547581 - Pyrimido-2-benzazepines and intermediates in their preparation (1985-10-15),
6. 4546183 - Pyrimido-2-benzazepines (1985-10-08),
7. 4481142 - Pyrimido-2-benzazepines (1984-11-06),
8. 4336388 - Thiazolyl benzophenone compounds (1982-06-22),
9. 4321199 - Thiazolo[5,4-d][2] benzazepines and intermediates (1982-03-23),
10. 4269774 - Thiazolo[5,4-d][2]benzazepines (1981-05-26),
11. 4157331 - Pyrazolo benzodiazepines (1979-06-05),
12. 4153799 - Pyrazol-1-yl benzodiazepines and oximes thereof (1979-05-08),
13. 4130716 - Pyrazolo benzodiazepines (1978-12-19),

Title: Innovations of Norman W. Gilman

Introduction

Norman W. Gilman is a notable inventor based in Wayne, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as dual antagonists of platelet activating factor. With a total of 13 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Gilman has developed compounds that are useful as bronchopulmonary agents. These compounds are designed to provide relief for conditions such as asthma and allergic reactions. The invention details specific chemical formulas where R1 is OR6 or NHR7, with R6 and R7 being various alkyl and phenyl groups. The compounds also include pharmaceutically acceptable salts, which enhance their effectiveness in medical applications.

Career Highlights

Gilman has had a distinguished career at Hoffmann-La Roche Inc., where he has been instrumental in advancing pharmaceutical research. His innovative work has led to the creation of new therapeutic agents that address critical health issues. His expertise in chemistry and pharmacology has positioned him as a leader in his field.

Collaborations

Throughout his career, Gilman has collaborated with esteemed colleagues such as Rodney I. Fryer and Eugene J. Trybulski. These partnerships have fostered a collaborative environment that has driven innovation and research in pharmaceutical sciences.

Conclusion

Norman W. Gilman's contributions to the field of pharmaceuticals through his numerous patents highlight his role as a significant inventor. His work continues to influence the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…